Seed VC · Hong Kong
GT Healthcare Capital Partners focuses on "globally leading, revolutionary innovative drugs and medical technologies," combining "technological progress and market application" as investment drivers, with a goal to "transform the medical technology landscape in Asia and globally."
Business models
deeptech_ip, biotech_therapeutics
Customer segments
Enterprise, Researchers, Government
Geography
UK, APAC, US
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
GT Healthcare Capital Partners writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks GT Healthcare Capital Partners alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. GT Healthcare Capital Partners is one of them, and we'll tell you exactly where they sit in your top 100.